They do, throughout the entire development process, but PAR previously mentioned organising a Type D meeting with the FDA for DMOAD discussions. I don't think PAR can successfully request a Type B or C meeting yet. It's possible for PAR to request a second Type D meeting after the first one, but each meeting takes 50 or 60 days to organise and that's assuming that the FDA grants it.
They do, throughout the entire development process, but PAR...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.5¢ | 28.5¢ | $79.93K | 274.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12951 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 23984 | 3 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |